as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
1.02%
Downside
5.84%
Upside
52 Week's Low
52 Week's High
59.14%
Downside
141.12%
Upside
Check Larimar Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$336.4M
EPS (TTM)
-1.7012
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-108.2M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
46533400.00%
Compare market cap, revenue, PE, and other key metrics of Larimar Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $336.4M | -73.94% | NA | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Larimar Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Larimar Therapeutics Inc investment value today
Current value as on today
₹59,861
Returns
Returns from Larimar Therapeutics Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Larimar Therapeutics Inc. Average target price of $19.3
Get share price movements and forecasts by analysts on Larimar Therapeutics Inc.
What analysts predicted
79.59%UPSIDE
Target Price
$19.3
Current Price
$3.94
Analyzed by
12 Analysts
Target
$19.30
Larimar Therapeutics Inc target price $19.3, a slight upside of 79.59% compared to current price of $3.94. According to 12 analysts rating.
Search interest for Larimar Therapeutics Inc Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:10% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, LRMR stock has moved up by 36.5%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 106.9%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 121.1%
Organisation | Larimar Therapeutics Inc |
Headquarters | Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004 |
Industry | Health Technology |
CEO | Dr. Carole S. Ben-Maimon M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Michael Celano CPA | Secretary & CFO |
Dr. Gopi Shankar M.B.A., Ph.D. | Chief Development Officer |
Mr. John Berman | Vice President of Finance & Administration |
Ms. Jennifer Spokes Johansson | Vice President of Legal & Compliance |
Dr. Russell G. Clayton Sr., D.O, D.O. | Chief Medical Officer |
Mr. Francis Michael Conway CPA | VP & Controller |
Dr. Carole S. Ben-Maimon M.D. | CEO, President & Director |
Larimar Therapeutics Inc share price today is $3.94 as on at the close of the market. Larimar Therapeutics Inc share today touched a day high of $4.17 and a low of $3.9.
Larimar Therapeutics Inc share touched a 52 week high of $9.5 on and a 52 week low of $1.61 on . Larimar Therapeutics Inc stock price today i.e. is closed at $3.94,which is 58.53% down from its 52 week high and 144.72% up from its 52 week low.
Larimar Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Larimar Therapeutics Inc (LRMR) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Larimar Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Larimar Therapeutics Inc share’s latest price of $3.94 as on September 13, 2025 at 1:29 am IST, you will get 2.5381 shares of Larimar Therapeutics Inc. Learn more about
fractional shares .
Larimar Therapeutics Inc stock has given -73.94% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?